Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01158820 · ClinicalTrials.gov registry record · Phase 4

Alternative Sedation During Bronchoscopy

A Phase 4 study of Sedation, sponsored by University of Pennsylvania.

Completed
Registry status
Phase 4
Development phase
50
Enrollment target
1
Study location

NCT01158820 is a Phase 4 study of Sedation that has completed, run by University of Pennsylvania. The registered enrollment target is 50 participants, below the 100,182-participant average among 12 other Sedation trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01158820, a Phase 4 study of Sedation, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
Phase 4
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure.

Conditions Studied

Interventions

  • DRUG Dexmedetomidine load
  • DRUG Ketamine load
  • DRUG Midazolam load
  • DRUG Fentanyl load
  • DRUG Dexmedetomidine maintenance

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2010-06
Est. Completion 2012-05
Phase Phase 4

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT01158820

The ClinicalTrials.gov registry entry for NCT01158820 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100,182-participant average among 12 other Sedation trials with a reported enrollment target (100% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sedation appearing as the primary indexed condition, and to 5 interventions - of which Dexmedetomidine load is the first listed.

NCT01158820 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01158820 about?

NCT01158820 is a clinical study titled "Alternative Sedation During Bronchoscopy". This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure.

What is the current status of trial NCT01158820?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2010-06. Estimated completion is 2012-05.

What conditions does trial NCT01158820 study?

This clinical trial studies the following conditions: Sedation.

What interventions are being tested in trial NCT01158820?

The interventions under investigation include: Dexmedetomidine load (DRUG), Ketamine load (DRUG), Midazolam load (DRUG), Fentanyl load (DRUG), Dexmedetomidine maintenance (DRUG).

Who is sponsoring clinical trial NCT01158820?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01158820 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sedation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.